HomeCompareHALL vs EQR

HALL vs EQR: Dividend Comparison 2026

HALL yields 2500.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HALL wins by $80609755877.33M in total portfolio value
10 years
HALL
HALL
● Live price
2500.00%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80609755877.37M
Annual income
$74,729,580,081,858,750.00
Full HALL calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — HALL vs EQR

📍 HALL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHALLEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HALL + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HALL pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HALL
Annual income on $10K today (after 15% tax)
$212,500.00/yr
After 10yr DRIP, annual income (after tax)
$63,520,143,069,579,940.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, HALL beats the other by $63,520,143,069,576,690.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HALL + EQR for your $10,000?

HALL: 50%EQR: 50%
100% EQR50/50100% HALL
Portfolio after 10yr
$40304877938.70M
Annual income
$37,364,790,040,931,290.00/yr
Blended yield
92.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

HALL
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
0.1
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HALL buys
0
EQR buys
0
No recent congressional trades found for HALL or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHALLEQR
Forward yield2500.00%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$80609755877.37M$40.5K
Annual income after 10y$74,729,580,081,858,750.00$3,819.61
Total dividends collected$80198875900.38M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: HALL vs EQR ($10,000, DRIP)

YearHALL PortfolioHALL Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$260,700$250,000.00$11,248$547.57+$249.5KHALL
2$6,370,070$6,091,121.50$12,701$666.53+$6.36MHALL
3$145,912,632$139,096,656.81$14,405$814.59+$145.90MHALL
4$3,133,830,814$2,977,704,297.75$16,413$999.84+$3133.81MHALL
5$63,122,812,060$59,769,613,088.96$18,795$1,232.92+$63122.79MHALL
6$1,192,683,724,131$1,125,142,315,226.76$21,639$1,527.95+$1192683.70MHALL
7$21,144,559,711,004$19,868,388,126,183.19$25,057$1,903.80+$21144559.69MHALL
8$351,818,906,448,043$329,194,227,557,269.44$29,197$2,385.87+$351818906.42MHALL
9$5,495,491,397,671,320$5,119,045,167,771,913.00$34,250$3,008.70+$5495491397.64MHALL
10$80,609,755,877,367,070$74,729,580,081,858,750.00$40,467$3,819.61+$80609755877.33MHALL

HALL vs EQR: Complete Analysis 2026

HALLStock

Hallmark Financial Services, Inc. underwrites, markets, distributes, and services property/casualty insurance products to businesses and individuals in the United States. The company operates through Specialty Commercial, Standard Commercial, and Personal segments. The Specialty Commercial segment offers primary and excess commercial vehicle insurance products and services; primary and excess liability, excess public entity liability, and E&S package and garage liability insurance products and services; primary and excess commercial property insurance for catastrophe and non-catastrophe exposures; healthcare and financial lines professional liability insurance products and services primarily for businesses, medical professionals, medical facilities, and senior care facilities; and satellite launch property/casualty insurance products and services, as well as various specialty programs. The Standard Commercial segment provides package and monoline property/casualty insurance products and services. The Personal segment offers non-standard personal automobile and renters insurance products and services. It markets its insurance products through independent general agents, retail agents, and specialty brokers. The company was incorporated in 1987 and is headquartered in Dallas, Texas.

Full HALL Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this HALL vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HALL vs SCHDHALL vs JEPIHALL vs OHALL vs KOHALL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.